Amanote Research
Register
Sign In
Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reducing the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis
Heart
- United Kingdom
doi 10.1136/heartjnl-2012-302920l.11
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Cardiology
Date
October 1, 2012
Authors
Unknown
Publisher
BMJ
Related search
Antiplatelet Therapy After Drug-Eluting Stent Implantation
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in China: A Large Single Center Study
Catheterization and Cardiovascular Interventions
Nuclear Medicine
Radiology
Cardiology
Cardiovascular Medicine
Imaging
Medicine
Short- Versus Long-Term Dual Antiplatelet Therapy After Second-Generation Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Antiplatelet Treatment With Cilostazol After Stent Implantation
Heart
Cardiovascular Medicine
Cardiology
The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication After Drug-Eluting StenT Implantation) Trial
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
Individualized Antiplatelet Therapy After Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Efficacy and Safety of 12 Versus 48 Months of Dual Antiplatelet Therapy After Implantation of a Drug-Eluting Stent: The OPTImal DUAL Antiplatelet Therapy (OPTIDUAL) Trial: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Very Late Drug-Eluting Stent Thrombosis After Nonsteroidal Anti-Inflammatory Drug Treatment Despite Dual Antiplatelet Therapy
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology